Oxandrin and Decadron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Oxandrin (oxandrolone) and Decadron (dexamethasone). Common drug interactions include neutropenia among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Oxandrin and Decadron. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Oxandrin?

Oxandrin has active ingredients of oxandrolone. eHealthMe is studying from 320 Oxandrin users. Check the latest studies of Oxandrin.

What is Decadron?

Decadron has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 47,210 Decadron users. Check the latest studies of Decadron.



On Jul, 14, 2026

22 people who take Oxandrin and Decadron together, and have interactions are studied.

Oxandrin and Decadron drug interactions.

What are the common drug interactions of Oxandrin and Decadron, by gender? *:

female:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Dehydration (dryness resulting from the removal of water)
  3. Dyspnoea (difficult or laboured respiration)
  4. Hypotension (abnormally low blood pressure)
  5. Infection
  6. Nausea (feeling of having an urge to vomit)
  7. Overdose
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Respiratory failure (excl neonatal) (inadequate gas exchange by the respiratory system(excluding neonatal))

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Asthenia (weakness)
  3. Vomiting
  4. Alopecia (absence of hair from areas of the body)
  5. Bone marrow failure
  6. Confusional state
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Diarrhoea
  9. Epistaxis (bleed from the nose)
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

What are the common drug interactions of Oxandrin and Decadron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Alopecia (absence of hair from areas of the body)
  2. Asthenia (weakness)
  3. Bone marrow failure
  4. Confusional state
  5. Death
  6. Decreased appetite
  7. Dehydration (dryness resulting from the removal of water)
  8. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  9. Diarrhoea
  10. Fatigue (feeling of tiredness)

30-39:

n/a

40-49:

n/a

50-59:

  1. Abdominal pain
  2. Burning sensation
  3. Constipation
  4. Death
  5. Decreased appetite
  6. Dry mouth
  7. Dysuria (painful or difficult urination)
  8. Epistaxis (bleed from the nose)
  9. Faeces hard
  10. Grand mal convulsion (a type of generalized seizure that affects the entire brain)

60+:

  1. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  2. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Pleural fibrosis (formation of fibrous tissue in lung)
  5. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  6. Thrombocytopenia (decrease of platelets in blood)
  7. Abdominal discomfort
  8. Asthenia (weakness)
  9. Constipation
  10. Decreased appetite

What are the existing conditions these people have? *

  1. Weight Decreased: 5 people, 22.73%
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 5 people, 22.73%
  3. Rectosigmoid Cancer (cancer that originates in the rectum and sigmoid colon): 2 people, 9.09%
  4. Rectal Cancer (cancer of rectum): 2 people, 9.09%
  5. Pancreatic Carcinoma (pancreatic cancer): 2 people, 9.09%
  6. Gastroesophageal Cancer: 2 people, 9.09%
  7. Brain Neoplasm Malignant (brain cancer tumour): 2 people, 9.09%
  8. Anal Cancer: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Oxandrin and Decadron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Oxandrin and Decadron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Oxandrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Decadron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxandrin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Decadron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on oxandrolone and dexamethasone (the active ingredients of Oxandrin and Decadron, respectively), and Oxandrin and Decadron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: